Raquel E. Izumi - 12 Aug 2024 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Reporting relationship: President and Chief Operations Officer, Director
Issuer ticker: VINC
Reported as of: 12 Aug 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Aug 2024, 20:00:04 UTC
Prior SEC filing: 29 May 2024
Source filing: View source filing
Reporting owner signature: By: /s/ Alexander A. Seelenberger, attorney-in-fact

Key filing fact

Raquel E. Izumi filed Form 4 for Vincerx Pharma, Inc. (VINC) on 14 Aug 2024.

Key facts

This page summarizes Raquel E. Izumi's Form 4 filing for Vincerx Pharma, Inc. (VINC).
12 reported transactions and 12 derivative rows are listed below.
Accepted by SEC: 14 Aug 2024, 20:00.

Change

Previous filing in this sequence was filed on 29 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VINC transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -76,500
Change %: -100%
Price
Shares after: 0
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 76,500
Exercise price: $6.26
Footnotes: F1, F2

VINC transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +76,500
Change %
Price
Shares after: 76,500
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 76,500
Exercise price: $0.5500
Footnotes: F1, F2

VINC transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -60,000
Change %: -100%
Price
Shares after: 0
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,000
Exercise price: $1.71
Footnotes: F1, F3

VINC transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +60,000
Change %
Price
Shares after: 60,000
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,000
Exercise price: $0.5500
Footnotes: F1, F3

VINC transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -60,000
Change %: -100%
Price
Shares after: 0
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,000
Exercise price: $0.8200
Footnotes: F1, F4

VINC transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +60,000
Change %
Price
Shares after: 60,000
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,000
Exercise price: $0.5500
Footnotes: F1, F4

VINC transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -90,000
Change %: -100%
Price
Shares after: 0
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $1.17
Footnotes: F1, F5

VINC transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +90,000
Change %
Price
Shares after: 90,000
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $0.5500
Footnotes: F1, F5

VINC transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -123,750
Change %: -100%
Price
Shares after: 0
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 123,750
Exercise price: $7.38
Footnotes: F1, F6

VINC transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +123,750
Change %
Price
Shares after: 123,750
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 123,750
Exercise price: $0.5500
Footnotes: F1, F6

VINC transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -41,250
Change %: -100%
Price
Shares after: 0
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 41,250
Exercise price: $7.38
Footnotes: F1, F6

VINC transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +41,250
Change %: +33%
Price
Shares after: 165,000
Date: 12 Aug 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 41,250
Exercise price: $0.5500
Footnotes: F1, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

On August 12, 2024, the stockholders of the Issuer approved the repricing of certain outstanding options to purchase common stock (the "Repriced Options"), with the new exercise price being the closing price of the Issuer's common stock on the Nasdaq Capital Market on August 12, 2024, rounded up to the nearest penny (the "Repricing"). There is no change to the number of shares underlying the Repriced Options or the vesting schedule or expiration dates of the Repriced Options. The Repricing was approved by the Board of Directors of the Issuer on June 26, 2024, based on the recommendation of the Compensation Committee of the Board of Directors.

Footnote F2

Option vests over three years, with 1/3 of the shares vesting on December 23, 2022, and 1/36th of the shares vesting monthly thereafter.

Footnote F3

Option vests in twenty-four equal monthly installments starting from August 25, 2022.

Footnote F4

Option vests in twenty-four equal monthly installments starting from November 15, 2022.

Footnote F5

Option vests in twenty-four equal monthly installments starting from February 15, 2023.

Footnote F6

One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.

SEC remarks

President and Chief Operations Officer